June 2009 Issue Table Of Contents
Source: Life Science Leader

Editor’s Note
Feature
Inside The Industry
- CMO Roundtable
- Has The Downturn Changed Dealmaking?
- What Impact Will The ARRA Have On Pharma?
- Centralization Of Biochemical Screening At AstraZeneca
- Strategies For Avoiding FCPA Liability
- Drug Reimportation: Helpful Or Harmful?
- Drug Approval Trends In Europe
- Choosing The UK For Translational Medicine
Industry Leader
This website uses cookies to ensure you get the best experience on our website. Learn more